Rna encoding a therapeutic protein
US-2025084141-A1 · Mar 13, 2025 · US
This page is not indexed by search engines while we improve data quality.
Hoerr Ingmar patents
Hoerr Ingmar is listed as an inventor on 68 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Hoerr Ingmar |
| Total patents | 68 |
| First publication | Jan 5, 2016 |
| Latest publication | Mar 13, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
RNA encoding a therapeutic protein
US-12227549-B2 · Feb 18, 2025 · US
Targets for rna therapeutics
US-2024285795-A1 · Aug 29, 2024 · US
Composition for treating prostate cancer (PCa)
US-12048738-B2 · Jul 30, 2024 · US
Rna encoding a tumor antigen
US-2024075116-A1 · Mar 7, 2024 · US
Rna encoding an antibody
US-2023293731-A1 · Sep 21, 2023 · US
PHARMACEUTICAL COMPOSITION CONTAINING A STABILISED mRNA OPTIMISED FOR TRANSLATION IN ITS CODING REGIONS
US-2023181765-A2 · Jun 15, 2023 · US
RNA encoding an antibody
US-11596699-B2 · Mar 7, 2023 · US
NUCLEIC ACIDS COMPRISING FORMULA (NuGlXmGnNv)a AND DERIVATIVES THEREOF AS IMMUNOSTIMULATING AGENT/ADJUVANT
US-2022401555-A1 · Dec 22, 2022 · US
Rna-coded antibody
US-2022372158-A1 · Nov 24, 2022 · US
Recent patents
Latest publications not already listed above.
RNA-coded antibody
US-11421038-B2 · Aug 23, 2022 · US
Pharmaceutical composition containing a stabilised mRNA optimised for translation in its coding regions
US-11369691-B2 · Jun 28, 2022 · US
Composition for treating lung cancer, particularly of non-small lung cancers (nsclc)
US-2022096616-A1 · Mar 31, 2022 · US
Rna encoding a therapeutic protein
US-2022025369-A1 · Jan 27, 2022 · US
Injection solution for rna
US-2021308238-A1 · Oct 7, 2021 · US
Pharmaceutical composition containing a stabilised mRNA optimised for translation in its coding regions
US-11135312-B2 · Oct 5, 2021 · US
RNA encoding a therapeutic protein
US-11078247-B2 · Aug 3, 2021 · US
NUCLEIC ACIDS COMPRISING FORMULA (NuGlXmGnNv)a AND DERIVATIVES THEREOF AS IMMUNOSTIMULATING AGENT/ADJUVANT
US-2020085942-A1 · Mar 19, 2020 · US
Pharmaceutical composition containing a stabilised mRNA optimised for translation in its coding regions
US-10568972-B2 · Feb 25, 2020 · US
Rna encoding an antibody
US-2020023076-A1 · Jan 23, 2020 · US
NUCLEIC ACID OF FORMULA (I): GlXmGn, OR (II): ClXmCn, IN PARTICULAR AS AN IMMUNE-STIMULATING AGENT/ADJUVANT
US-2020016264-A1 · Jan 16, 2020 · US
COMPOSITION FOR TREATING PROSTATE CANCER (PCa)
US-2019365879-A1 · Dec 5, 2019 · US
Rna encoding a tumor antigen
US-2019343942-A1 · Nov 14, 2019 · US
Nucleic acid comprising GlXmGn as an immune-stimulating agent/adjuvant
US-10441653-B2 · Oct 15, 2019 · US
Composition for treating prostate cancer (PCa)
US-10434154-B2 · Oct 8, 2019 · US
Rna-coded antibody
US-2019284260-A1 · Sep 19, 2019 · US
Rna encoding a therapeutic protein
US-2019241633-A1 · Aug 8, 2019 · US
PHARMACEUTICAL COMPOSITION CONTAINING A STABILISED mRNA OPTIMISED FOR TRANSLATION IN ITS CODING REGIONS
US-2019134222-A1 · May 9, 2019 · US
Pharmaceutical composition containing a stabilised mRNA optimised for translation in its coding regions
US-10188748-B2 · Jan 29, 2019 · US
Composition for treating lung cancer, particularly of non-small lung cancers (nsclc)
US-2018256694-A1 · Sep 13, 2018 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Curevac Ag | 60 |
| CureVac SE | 8 |
| Hoerr Ingmar | 4 |
| Probst Jochen | 3 |
| Pascolo Steve | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 58 |
| A61K2039/53 | 55 |
| A61P37/04 | 52 |
| A61K48/00 | 42 |
| A61K39/0011 | 38 |